- Investors
Advancing the next generation of cancer therapies
Ymmunobio brings together leaders in immunology, oncology, cell biology, and drug development to build a differentiated pipeline of novel, first-in-class antibodies designed to address resistance to today’s treatments. With a protected IP position and strategic collaborations, we’re translating strong preclinical results into programs with clear development paths.
If you’d like to learn more about our work, partnering opportunities, or upcoming milestones, please reach out at info@ymmuno.bio. or use the form below.
- Downloads & Documents
Useful information for investors
Presentations & Factsheets
Scientific Publications & Literature (Coming Soon)
3rd place in biotech startup 2024
Our proud partners
- Contact us
Get in touch
We want to hear from you. Please use the contact form and follow us on Linkedln to keep with the Ymmunobio news!